Tech Company Financing Transactions

Navigator Medicines Funding Round

Forbion Capital Partners, RA Capital Management and private investors participated in a $100 million Series A funding round for Navigator Medicines. The round closed on 8/27/2024.

Transaction Overview

Announced On
8/27/2024
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series A
Investors

Forbion Capital Partners (Lead Investor)

RA Capital Management (Lead Investor) (Joustra Levin)

Proceeds Purpose
The company intends to use the funds for the development of NAV-240, as well as a pipeline of OX40L-targeted mono- and bispecific antibodies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Scotch Plains, NJ Undisclosed
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Leading the advancement of biologics for targeted immune regulation & restoration.
Profile
Navigator Medicines LinkedIn Company Profile
Social Media
Navigator Medicines Company Twitter Account
Company News
Navigator Medicines News
Facebook
Navigator Medicines on Facebook
YouTube
Navigator Medicines on YouTube

Management Team

Title
Name
Email & Social
Chief Medical Officer
Dana McClintock
  Dana McClintock LinkedIn Profile  Dana McClintock Twitter Account  Dana McClintock News  Dana McClintock on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/27/2024: Linker Finance venture capital transaction
Next: 8/27/2024: Fusion Consulting Group venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary